Donor-specific phenotypic variation in hiPSC cardiomyocyte-derived exosomes impacts endothelial cell function.
Adult
Aged
Case-Control Studies
Cell Differentiation
Cell Movement
Cell Proliferation
Cell Separation
Cells, Cultured
Exosomes
/ genetics
Female
Gene Expression Regulation
Humans
Hypertrophy, Left Ventricular
/ genetics
Induced Pluripotent Stem Cells
/ metabolism
Male
MicroRNAs
/ genetics
Middle Aged
Myocytes, Cardiac
/ metabolism
Neovascularization, Physiologic
/ genetics
Phenotype
RNA, Messenger
/ genetics
Signal Transduction
Tissue Donors
Transcriptome
cardiomyocyte hypertrophy
exosomes
human induced pluripotent stem cells
intercellular communication
miRNA
Journal
American journal of physiology. Heart and circulatory physiology
ISSN: 1522-1539
Titre abrégé: Am J Physiol Heart Circ Physiol
Pays: United States
ID NLM: 100901228
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
pubmed:
9
1
2021
medline:
23
3
2021
entrez:
8
1
2021
Statut:
ppublish
Résumé
Exosomes are an important mechanism of cell-cell interaction in the cardiovascular system, both in maintaining homeostasis and in stress response. Interindividual differences that alter content in exosomes may play a role in cardiovascular disease pathology. To study the effect of interindividual cardiomyocyte (CM) variation, we characterized exosomal content in phenotypically diverse human induced pluripotent stem cell-derived CMs (hiPSC-CMs). Cell lines were generated from six participants in the HyperGEN cohort: three with left ventricular hypertrophy (LVH) and three with normal left ventricular mass (LVM). Sequence analysis of the intracellular and exosomal RNA populations showed distinct expression pattern differences between hiPSC-CM lines derived from individuals with LVH and those with normal LVM. Functional analysis of hiPSC-endothelial cells (hiPSC-ECs) treated with exosomes from both hiPSC-CM groups showed significant variation in response, including differences in tube formation, migration, and proliferation. Overall, treatment of hiPSC-ECs with exosomes resulted in significant expression changes associated with angiogenesis and endothelial cell vasculogenesis. However, the hiPSC-ECs treated with exosomes from the LVH-affected donors exhibited significantly increased proliferation but decreased tube formation and migration, suggesting angiogenic dysregulation.
Identifiants
pubmed: 33416449
doi: 10.1152/ajpheart.00463.2020
pmc: PMC8294700
doi:
Substances chimiques
MicroRNAs
0
RNA, Messenger
0
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
H954-H968Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL055673
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL125580
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01HL107437
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL055673
Pays : United States
Références
Cardiovasc Res. 2014 May 1;102(2):249-57
pubmed: 24591150
Nat Rev Cardiol. 2017 Apr;14(4):238-250
pubmed: 28004807
Neth Heart J. 2013 Jul;21(7-8):367-71
pubmed: 23864481
Oncotarget. 2017 May 30;8(22):36137-36148
pubmed: 28410224
Stem Cells. 2017 Apr;35(4):851-858
pubmed: 28294454
Cardiovasc Res. 2006 Jul 15;71(2):342-51
pubmed: 16698001
Mol Cancer. 2019 Dec 10;18(1):181
pubmed: 31823788
Circ Res. 2017 Jan 20;120(2):407-417
pubmed: 28104773
J Clin Invest. 2007 Nov;117(11):3176-9
pubmed: 17975662
Vascul Pharmacol. 2015 Aug;71:24-30
pubmed: 25869502
Stem Cell Res Ther. 2015 Apr 10;6:10
pubmed: 26268554
J Clin Invest. 2017 Apr 3;127(4):1375-1391
pubmed: 28319051
J Am Heart Assoc. 2015 Feb 24;4(2):
pubmed: 25713289
Circulation. 2018 Apr 17;137(16):1712-1730
pubmed: 29233823
Elife. 2020 Jan 24;9:
pubmed: 31976858
Stem Cells. 2009 Jan;27(1):230-7
pubmed: 18772313
Circ Res. 2015 Jun 19;117(1):89-98
pubmed: 26089366
Cardiovasc Res. 2017 Sep 1;113(11):1338-1350
pubmed: 28859292
Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29
pubmed: 26153368
Science. 2009 May 8;324(5928):797-801
pubmed: 19325077
Genome Biol. 2014;15(12):550
pubmed: 25516281
FASEB J. 2010 Sep;24(9):3186-95
pubmed: 20400538
Heart Fail Rev. 2013 Sep;18(5):607-22
pubmed: 22948484
Cell Cycle. 2006 Mar;5(5):512-8
pubmed: 16552185
Circ Res. 2013 Feb 1;112(3):523-33
pubmed: 23371901
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Nature. 2016 Oct 20;538(7625):388-391
pubmed: 27723741
Clin Cardiol. 1993 May;16(5 Suppl 2):II10-4
pubmed: 8504584
Circ Heart Fail. 2016 Apr;9(4):e002760
pubmed: 27056881
Sci Rep. 2016 Mar 02;6:22519
pubmed: 26931825
Stem Cell Reports. 2014 May 08;2(5):606-19
pubmed: 24936449
Stem Cells Transl Med. 2017 Jan;6(1):209-222
pubmed: 28170197
Front Physiol. 2016 Mar 18;7:98
pubmed: 27047385
Nat Biomed Eng. 2018 May;2(5):293-303
pubmed: 30271672
Cytotherapy. 2018 Mar;20(3):291-301
pubmed: 29434006
J Cell Sci. 2015 Oct 1;128(19):3556-68
pubmed: 26136364
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
J Cell Mol Med. 2018 Oct;22(10):4568-4587
pubmed: 29956461
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Int J Cardiol. 2015 Aug 1;192:61-9
pubmed: 26000464
Mol Ther. 2018 Jul 5;26(7):1624-1634
pubmed: 29699941
J Biol Chem. 2002 Jul 5;277(27):24453-9
pubmed: 11983702
Physiol Genomics. 2018 Feb 1;50(2):77-97
pubmed: 29187515
Genomics Proteomics Bioinformatics. 2015 Feb;13(1):17-24
pubmed: 25724326
Exp Mol Med. 2019 Nov 13;51(11):1-11
pubmed: 31723119
Circulation. 2015 Mar 17;131(11):1019-30
pubmed: 25779542
Circ Res. 2014 Jan 31;114(3):565-71
pubmed: 24481846
J Cardiovasc Transl Res. 2010 Aug;3(4):330-43
pubmed: 20559774
Sci Rep. 2016 Jan 14;6:19464
pubmed: 26763872
Oxid Med Cell Longev. 2014;2014:260429
pubmed: 25101151
Development. 2012 Dec 1;139(23):4356-64
pubmed: 23132244
Lab Chip. 2020 Mar 17;20(6):1153-1166
pubmed: 32100769
Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):211-7
pubmed: 12588761
Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2006-17
pubmed: 21890694
Circulation. 2010 Aug 31;122(9):928-37
pubmed: 20805439
Int J Obes (Lond). 2016 Jan;40(1):102-11
pubmed: 26122028
J Clin Invest. 2019 Apr 29;129(6):2237-2250
pubmed: 31033484
Cell Signal. 2017 Jan;29:84-95
pubmed: 27742560
Theranostics. 2017 Jan 26;7(3):789-804
pubmed: 28255367
Eur Heart J. 2017 Jan 14;38(3):201-211
pubmed: 28158410
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Nat Med. 2016 May;22(5):547-56
pubmed: 27089514
J Transl Med. 2019 Mar 11;17(1):75
pubmed: 30871557
Nat Biotechnol. 2018 Aug;36(7):597-605
pubmed: 29969440
Front Mol Neurosci. 2011 Dec 02;4:51
pubmed: 22144946